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ABSTRACT  
Trace elements exist in the environment in small amounts but 
play an essential part in sustaining various physiological and 
metabolic processes occurring within living tissues, as 
enzymes structure and function, bone and blood maintenance, 
immune responses or transmission of nerve impulses. They 
must be obtained from diet, being a varied and balanced diet 
important for obtaining a series of elements necessary for our 
body. The total amount of a mineral in a food that is 
dependent on digestion, its release from the food matrix and 
the absorption rate by the intestinal cells. If minerals are not 
supplied in adequate quantities, signs and symptoms of trace 
elements deficiencies appear. Beyond the nutritional aspects, 
trace elements have applications in the pharmaceutical 
industry, integrating pharmacologically active compounds. 
Usually, in the form of metal complexes, these metal-based 
drugs are used as anticancer therapeutics, anti-
inflammatories, antidiabetic drugs or antimicrobial agents. 
This evolving field is developing metal complexes with 
remarkable actions, and new metal-based drugs are emerging 
every year. This article aims to review the main effects of 
trace elements in human health, namely iron, zinc, copper, 
manganese and fluorine, focusing on the physiopathology and 
consequences of lack or excess of these elements. Also, it 
offers an overview of research information published in 
recent years concerning the use of these metals in compounds 
that show promising pharmacological activities. 
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INTRODUCTION 
Minerals are inorganic substances that are present in the tissues and fluids of the human body. 
They are divided into: (i) macrominerals (main minerals) and (ii) microminerals (secondary 
minerals). Calcium (Ca), magnesium (Mg), potassium (K), sodium (Na), chlorine (Cl), 
phosphorus (P) and sulphur (S) are considered as macrominerals because they are needed in 
greater quantity. Microminerals are iodine (I), zinc (Zn), selenium (Si), iron (Fe), manganese 
(Mn), copper (Cu), cobalt (Co), molybdenum (Mo), fluorine (F), chromium (Cr) and boron 
(B), which we need to consume in small quantities. Both are important for good health and 
should be consumed according to the needs of the organism 1, 2, 3. Microminerals, including 
trace and ultra-trace elements, play a vital role in maintaining integrity of various 
physiological and metabolic processes occurring within living tissues 4. 
The words “trace elements” are used for elements existing in natural and perturbed 
environments in small amounts, with excess bioavailability having a toxic effect on the living 
organism. The ten main trace elements include iron, copper, zinc, manganese, fluorine, 
bromine, rubidium, silicon, strontium and lead. Among these, iron is the most abundant in 
human serum, followed by zinc and copper. On the other hand, cobalt, iodine, selenium, 
boron, molybdenum and chromium, among others, are ultra-trace elements and are present in 
least amounts (at ppb order) 5. 
Minerals are necessary for the bone strengthening, the transmission of nerve impulses or the 
enzymatic structure. The existence of a significant variety of minerals in our organism is 
related to the different functions they have, although some play similar roles. Microminerals 
(Cu, Fe, Mn, Se and Zn) play an important role in the structural fraction of enzymes, in the 
formation of erythrocyte cells (Co, I and Fe), in the regulation of glucose levels of activation 
of antioxidant enzymes (Mo), and maybe involved in the various processes of the immune 
system (Cu, Se and Zn) 2. 
Since minerals are not produced by living beings but perform functions essential to the 
human organism, they must be obtained through diet 6,7. There are several food sources that 
can be used to obtain macro and microminerals, being a varied and balanced diet, rich in 
vegetables and fruits, and food of animal origin, important for obtaining a series of elements 
necessary for our body 2, 3. 
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The total amount of a mineral in a food does not reflect the amount that will be available in 
the body for absorption. The bioavailability of a mineral is defined as the ingested fraction 
thereof that is absorbed and, in turn, used for physiological functions. Consequently, the 
bioavailability of a mineral is dependent on digestion, its release from the food matrix, the 
absorption rate of the target ingredient by the intestinal cells and the amount that is 
transported to the cells1, 2. 
In general, minerals present in ingested foods are absorbed into the different parts of the 
gastrointestinal tract (duodenum, jejunum and ileum). Minerals that are absorbed by the 
intestinal epithelial cells are transferred through the cytosol and transported through the 
membrane into the blood by an active transport mechanism. If a mineral is not transported 
through the membrane, it will remain in the intestinal cell connected to the proteins. For 
instance, iron ions bind to ferritin and zinc to metallothionein. Minerals that are not absorbed 
are usually excreted in the faeces. This mechanism appears to occur to protect the body 
against the potential toxicity that excessive absorption of minerals can cause 1, 2. 
If minerals are not supplied in adequate quantities, deficiencies arise, which can manifest 
themselves through specific and non-specific symptoms. A severe deficiency of an essential 
mineral can only be corrected by supplementing the element concerned. In fact, the amount 
of minerals supplied by food is not always enough to meet the needs if the bioavailability of 
the mineral is low. Then, to become bioavailable, the minerals must be absorbable and 
therefore bioaccessible 7. 
Nowadays, besides the nutritional aspects, minerals have several applications, being the 
pharmaceutical and cosmetic industries one of their areas of intervention 8, 9, 10, 11. There are, 
in the pharmaceutical market, a variety of medicinal products whose composition integrates 
trace minerals, such as iron, zinc, manganese, among others. These elements are considered 
especially important because of their physiological roles and their participation in a variety of 
biological processes 12, 13. 
Metal-based drugs are inorganic compounds that have been used in medicinal chemistry as 
therapeutic agents for a long time. These metal complexes were successfully applied as 
anticancer therapeutics, anti-inflammatories, antidiabetic drugs, antimicrobial agents or in the 
treating of specific conditions, such as Diabetes Mellitus, Huntington’s disease, 
atherosclerosis or Wilson’s disease, among others 14, 15, 16. The use of metallodrugs as 
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effective pharmaceuticals shows that is possible to control the cytotoxicity of metal ions by 
the appropriate choice of ligands 14. 
Since redox metabolism of cancer cells is different from healthy tissues and enhanced levels 
of Intracellular Reactive Oxygen Species (ROS) are often observed in tumor cells, interacting 
with the cellular redox homeostasis of cancer seems to be a promising approach for cancer 
therapy17. Anticancer metal complexes (including copper and manganese) have been shown 
to strongly interfere with or even disturb cellular redox homeostasis. Changes of the redox 
conditions, upregulation of oxidative stress and its molecular consequences for malignant 
tumors are the guidelines for the development of innovative redox-active metal drugs 11, 17.  
Due to the variability in opinions of the role and effect of trace elements in human health this 
article offers an overview of research information, focusing on trace minerals such as iron, 
zinc, copper, manganese and fluoride in connection with human condition.  
Iron (Fe) 
Iron is an essential element for almost all living organisms because it participates in a wide 
range of metabolic processes, including oxygen transport, synthesis of deoxyribonucleic acid 
(DNA) and electron transport. This metal also plays important roles during inflammation and 
the immune response to infection. However, as this mineral can form free radicals, its 
concentration in the body must be carefully regulated, since its excess can cause tissue 
damage. Disorders related to iron metabolism are among the most common health problems 
in humans and cover a broad spectrum of diseases with diverse clinical manifestations, 
ranging from deficiency to iron overload and neurodegenerative diseases 9, 18, 19. 
Animal offal, especially liver, red meat, miscellaneous cereals, nuts and shellfish are 
important sources of Fe, depending the recommended daily intake for elemental iron age and 
sex (adult male - 8 mg; adult female - 18 mg) 20, 21. There are compounds that can inhibit or 
facilitate the absorption of iron from food, which occurs mainly in the duodenum and upper 
jejunum. Inhibitors include phytates, polyphenols (tannins, phenolic acid and flavonoids), 
dietary fiber, protein and calcium. Absorption of iron is facilitated by meat, fish, poultry, 
ascorbic acid, citric acid and amino acids 9, 18, 22. 
Nutritional iron exists in two chemical forms: heme iron, which is found in hemoglobin, 
myoglobin and some enzymes, and is bioavailable; and non-heme iron, which exists mainly 
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in foods of vegetable origin, but also in some animal sources, as well as non-heme enzymes 
and ferritin 1, 23.  
In a healthy individual, iron is maintained at stable concentrations in plasma and tissues, 
primarily by regulating iron absorption from food and preserving iron stores in the body. This 
systemic iron homeostasis is controlled by a variety of proteins, with hepcidin being the main 
regulator through its binding to ferroportin 1. Iron deficiency can lead to anemia, which is 
characterized in this case by the production of smaller erythrocytes and by a decrease of 
circulating hemoglobin 1, 9.  
Based on prevalence and health effects, iron deficiency anemia is considered a major public 
health problem. The foremost factors leading to the high prevalence of this deficiency are: 
i) blood loss (excessive menstrual flow in women, hemorrhage from injury or chronic loss of 
blood due to stomach ulcer, hemorrhoids, varicose veins, parasites, ulcerative colitis or 
malignant diseases of the uterus and colon); ii) low intake of bioavailable iron, due to 
vegetarian eating with insufficient intake of heme iron; iii) inadequate absorption, resulting 
from possible diarrhea and intestinal disorders such as celiac disease, atrophic gastritis, 
partial or total gastrectomy, or interference of various drugs; iv) the existence of inhibitors in 
food diets (e. g. cereals and vegetables); v) increased iron needs, which were not achieved 
during childhood, adolescence, pregnancy and lactation for the growth of blood volume; and 
vi) failure to release iron from plasma reserves and defective use of this mineral due to 
inflammation or chronic disease 1, 9, 24. 
Anemia can be corrected by administering oral iron supplements, namely iron(II) salts in high 
doses, being more common the use of ferrous sulfate or ferrous gluconate, which are the most 
applied because of its low cost and high bioavailability. To prevent possible iron deficiency, 
individuals should always be advised to have a feed with an appropriate iron intake 24. 
On the other hand, hemochromatosis is a genetically determined form of iron overload that 
results in progressive lesions in the liver, pancreas, heart and other organs, as individuals 
absorb three times more iron from food than those who do not suffer from this disease. Men 
are particularly susceptible to this disease because they do not have physiological 
mechanisms for iron release, such as menstruation, pregnancy and lactation 1. 
Iron has been searched due to its antibacterial activity. Nanocatalysts of single iron atoms 
isolated in nitrogen-doped carbon could effectively catalyze the peroxidase-like reaction, 
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producing hydroxyl radical to kill bacteria of both Gram positive (Staphylococcus aureus) 
and Gram negative (Escherichia coli) in the presence of H2O2. In vivo, these single iron atom 
nanocatalysts eradicated bacterial infections propagated at wounds by E. coli and S. aureus 
pathogens 25. 
Two iron(III) complexes bearing the tripodal aminobisphenolate ligand were synthezised and 
studied. These compounds showed to be cytotoxic against both human triple-negative breast 
adenocarcinoma and human cervical carcinoma, in addition to good anti-Mycobacterium 
tuberculosis activity 26. 
Tidjani and co-workers synthesized and characterized mixed iron(III) complexes containing 
amino acids and isonitrosoacetophenone 27. These compounds showed to be potent anticancer 
agents with potential to be developed as anticancer drugs. The antimicrobial activity of these 
Fe(III) complexes was also investigated against both Gram positive and negative bacteria 
(Staphylococcus aureus, Bacillus subtilis, Escherichia coli, Pseudomonas aeruginosa) and 
fungi (Candida albicans), revealed that iron compounds were more active against Gram 
positive bacteria. The complexes also showed a good antifungal activity, having considerable 
growth inhibition against Candida albicans. 
Ye and colleagues have studied the anticancer effect and the pharmacological mechanism of 
a Fe(II) phenanthroline complex 28. This iron complex was selectively transported into 
esophageal squamous cell carcinoma cells overexpressing transferrin receptor 1 (TFR1) 
through TFR1-mediated endocytosis and showed anticancer activity in a dose-dependent 
manner. The Fe(II) complex caused cell cycle arrest at the G0/G1 phase by blocking the 
CDK4/6-cyclin D1 complex and induced mitochondria-mediated apoptosis. Exposure to the 
Fe(II) complex also originates excessive reactive oxygen species accumulation by 
thioredoxin reductase inhibition and DNA double-strand breaks, which in turn sequentially 
activated ATM, CHK1/2 and p53. Combination treatment of Fe(II) complex with cisplatin 
exhibited a synergistic effect in ESCC cells, indicating potential use of this iron compound in 
esophageal squamous cell carcinoma cells chemotherapy, mainly for patients with TFR1 
overexpression. 
A nanomedicine that can attain tumor-specific chemotherapeutic drug release and ROS 
generation was developed, with iron oxide nanoparticles encapsulated and β-lapachone in a 
nanostructure assembled by H2O2-responsive polyprodrug polymer 
29. The antitumor effect of 
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this tumor‐specific drug release and ROS generation was showed in vitro and in vivo, being a 
potential combination therapy for cancer chemo/chemodynamic.  
Two isothiocyanato iron(III) complexes with 2,2′-[2,6-pyridinediylbis(ethylidyne-1-
hydrazinyl-2-ylidene)]bis[N,N,N-trimethyl-2-oxoethanaminium] dichloride (H2LCl2) ligand 
have been synthesized and studied 30. Cytotoxic activity of Fe(III) complexes was tested 
against five human cancer cell lines and normal cell line, being the results compared with the 
obtained for Co(II), Ni(II), Mn(II), Zn(II) and Cd(II) complexes with the same ligand 
previously synthesized 31, 32, 33, 34. The cytotoxic activities of the complexes were lower 
against all malignant cell lines than the activity of cisplatin (positive control) and the best 
activity was observed for Fe(III), Co(II) and Cd(II) complexes. Iron(III) complexes also 
showed better antimicrobial activity than the ligand H2LCl2 and FeCl3·6H2O, but their 
Minimum Inhibitory Concentration (MIC) values were higher than the values for standard 
antimicrobial agents. Both complexes revealed better activity against Gram positive than 
Gram negative bacterial strains, being the highest activity observed against B. subtilis 30.  
A Fe(II) complex with a Schiff base ligand derived from 2-amino-3-hydroxypyridine and 3-
methoxysalicylaldehyde has been prepared 35. Schiff base ligand, Fe(II) complex and the 
corresponding nano-sized metal oxide in vitro biological activities have been tested against 
Gram negative bacteria (Escherichia coli and Serratia marcescence) and Gram positive 
bacteria (Micrococcus luteus) and three strains of fungus (Aspergillus flavus, Getrichm 
candidum and Fusarium oxysporum). The iron complex revealed to possess more 
antimicrobial activity than the free Schiff-base chelate, but it nano-sized metal oxide has the 
highest activity. Fe(II) complex also interact with DNA through intercalative binding mode 
and showed cytotoxic activity on human colon and hepatic carcinoma cells. 
Zinc (Zn) 
Zinc is the second most prevalent vestigial element in the human body, and it is essential for 
individuals to remain healthy (the recommended dietary intake, expressed as elemental Zn, is 
11 mg and 9 mg for adult male and female, respectively). Since the human body does not 
store excess zinc, it must be consumed regularly as part of the diet. Common dietary sources 
of Zn include red meat, poultry and fish 1, 36. 
Zinc performs a wide variety of functions in the human body, such as maintenance of 
physiological processes, metabolism, signalling, transduction, cell growth and differentiation. 
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Due to its size and charge characteristics, zinc is used by numerous proteins to stabilize the 
structure and assist its function. These proteins are largely enzymes and transcription factors, 
which are involved in many processes that include growth and immune function 1, 36, 37, 38.  
Zn is still important for the catalytic activity of various enzymes, on immune function, on 
protein synthesis, on wound healing, on DNA synthesis and on cell division. This mineral is 
also essential for the normal development of pregnancy, as well as for growth during 
childhood and adolescence 38. Thus, their deficiency can lead to oligospermia, loss of weight 
and hyperammonemia, delayed growth, hypogonadism in males, rough skin, lack of appetite, 
delayed wound healing, palate, olfaction and night vision impairment, bullous-pustular 
dermatitis, alopecia, diarrhea, weight loss, anorexia, depression and intercurrent infections. A 
severe zinc deficiency, if not detected, can even be fatal 10, 37, 39. 
The zinc toxicity is considered extremely rare, as it is considered a non-toxic mineral, 
especially when administered orally. However, excessive intake may lead to symptoms such 
as nausea, vomiting, epigastric pain, lethargy, and fatigue. When there is zinc intake ten to 
twenty times higher than the daily recommended amounts, copper deficiency may occur and 
consequently symptoms of anemia and neutropenia 10. 
Zinc is mainly absorbed at the duodenum. It binds to many proteins in plasma, including 
albumin. Food and drink reduce the absorption of this mineral, varying its bioavailability 
with the inorganic salt. In fact, food intake is not a guarantee of cellular use of this mineral, 
since chemical interaction with other substances such as oxalates, phytates, fibers and other 
minerals may occur, damaging the absorption and limiting its bioavailability. Phytates can 
bind to zinc, forming insoluble complexes at alkaline pH. Likewise, the absorption of zinc is 
decreased by the presence of phosphates and calcium in the diet. However, animal proteins 
appear to increase zinc absorption, perhaps because their amino acids keep zinc in a soluble 
form. Zinc excretion is mainly through the faeces, with a small percentage of this mineral 
being excreted in the urine36, 38, 39, 40. 
Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disease produced by the inability of 
the pancreas to increase insulin secretion to balance its decreased activity in insulin-sensitive 
tissues, resulting in a persistent hyperglycemia condition 16, 41. Zinc is an essential mineral to 
the endocrine pancreas, where it is insignificant concentration, participating in various 
functions related to blood glucose homeostasis. Appropriate or increased amounts of zinc in 
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the pancreas may be beneficial in T2DM, favouring the construction of insulin hexamers and 
regulation of insulin and glucagon secretion, as well as hepatic clearance of insulin. Zinc 
sulphate supplementation of patients seems to have beneficial effects because by raising the 
concentration of this mineral in the serum, there is an improvement in glycemic control 16, 41, 
42. 
Childhood is a critical phase of life, which requires adequate nutrition to sustain growth and 
development. Zinc deficiency is an important health problem that particularly affects young 
children and contributes to the occurrence of infectious diseases, including diarrhea, 
pneumonia and malaria. Zinc deficiency is a key factor in increasing the susceptibility to 
infection found in nutritional deficiency states, in which case supplementation of the mineral 
is recommended, more precisely with zinc sulfate 40, 43. 
Wilson’s disease is an autosomal recessive genetic disorder characterized by decreased 
copper incorporation into ceruloplasmin and consequently increased excretion of copper, 
resulting in accumulation of toxic compounds in the liver, brain, and other tissues and organs. 
Toxic copper reserves can be removed with chelation therapy or with zinc to inhibit the 
absorption of intestinal copper. Zinc sulfate is important in the treatment of this disease and 
should be applied when other therapies are not showing the expected results. Zinc has a 
different mechanism of action from oral chelators and therefore may serve as a substitute for 
these drugs in the treatment of this disease when intolerance develops or for maintenance 
therapy after liver transplantation 44, 45. 
Recent research suggests that, in hepatocytes, zinc may potentiate certain mechanisms of cell 
function that protect the cell from potential damage. For these reasons, zinc is considered a 
potentially effective treatment for Wilson’s disease. Clinical experience has shown that zinc, 
administered as a salt, is effective as maintenance therapy in patients who were initially 
treated with an oral chelator, including those who became intolerant of this chelator. The 
major problem with zinc is that it requires a consistent dosage of three times a day and thus 
non-adherence to therapy may limit its overall effectiveness 44. 
Zinc seems to play an important role in the treatment of alcoholic liver disease. Since zinc 
deficiency is an important factor in the development and progression of this disease, taking 
supplementation in Zn may act as a reversal of zinc deficiency. However, it should be noted 
that, although zinc is innocuous compared to other metal ions having similar chemical 
www.ijsrm.humanjournals.com 
Citation: Ana F. Vinha et al. Ijsrm.Human, 2019; Vol. 13 (3): 57-80. 
66 
properties, administration of the same in high doses may affect copper homeostasis. 
Therefore, careful monitoring of zinc and copper is required during this supplementation 
therapy 37.  
In addition to the aforementioned pathologies, where Zn supplementation has positive results, 
zinc sulfate has been successfully applied in the treatment of various diseases and health 
problems, such as enteropathic acrodermatitis, anorexia nervosa, arthritis, diarrhea, 
malabsorption syndrome, ocular irritation, infection control, infertility, senile dementia, 
sickle cell anemia, thalassemia and constipation 38. 
Zn(II) complexes nitroporphyrins derivatives showed HIV-1 entry inhibition and in vitro 
photodynamic activity towards human lung cancer cells, being these antiviral and anti-cancer 
properties improved by the incorporation of Zn(II) in the free ligand 46. 
Hussain and co-workers have designed and synthesized a zinc complex of benzimidazole 
derived organic moiety that revealed potential in vitro anticancer activity against five cancer 
cell lines, specifically HepG2 (liver), SK-MEL-1 (skin), HT018 (colon), HeLa (cervical) and 
MDA-MB231 (Breast), and no activity was observed with the free ligands. The complex 
showed a significant binding affinity with DNA, this being an important aspect of the metal-
based anticancer chemotherapeutic. The degree of toxicity of this potential antitumor drug 
was very low 47. 
Liu and colleagues synthesized a Zn(II)-based coordination polymer, 
{(H2NMe2)2[Zn3(BTB)2(OH)(Im)](DMF)9(MeOH)7}n (H3BTB=1,3,5-benzenetrisbenzoic 
acid, Im=imidazole, DMF=N,N-dimethylformamide), and studied it in vitro anticancer 
activity on four human liver cancer cells 48. Although the ligands H3BTB and Im did not 
show anticancer activity against these cell lines, zinc incorporation became the coordination 
polymer effective in anticarcinogenic properties. 
The antibacterial and antifungal properties of derived thiophene-2-carboxamide zinc 
complexes were investigated. These compounds revealed significant or moderate activity 
against four Gram negative (E. coli, S. sonnei, P. aeruginosa and S. typhi) and two Gram 
positive (S. aureus and B. subtilis) bacterial, being, for most of the strains, more effective 
than the free ligands. The antifungal activity was more significant for C. albican, A. Flavus 
and C. glaberata, depending on the ligand, however, against one or more fungal strains the 
bioactivity of the ligands is more evidente 49. 
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Copper (Cu) 
Copper, an essential trace element, is present in the human body in an approximate amount of 
100 mg. The normal Cu intake by an adult is about 1-4 mg/day, with vegetables being one 
important source 20. It is involved in a plethora of biological processes, from immune and 
neural functions to bone and blood health, or antioxidant defense. Most of these roles are 
performed by metalloproteins and enzymes, to which copper is mostly bound, acting both 
structurally and as a cofactor for catalytic activity 20. Ceruloplasmin is the most abundant 
copper containing enzyme (it accounts for 95% of human plasma copper), being a 
ferroxidase, which makes it have antioxidative properties 50.  
Dietary copper deficiency can result in adverse consequences. Although severe Cu deficiency 
is relatively straightforward to diagnose, identifying marginal deficiency is problematic 51. 
The mean time described from onset of symptoms to diagnosis in mild deficiency was 1.1 
years 52. Copper deficiency is a known cause of anemia and neutropenia. Hypocupremia is 
associated with excess zinc intake, which competes with copper for intestinal absorption, but 
also with gastric surgery, malabsorption, and excess copper chelation 53. Similar to cobalamin 
deficiency, hypocupremia can also lead to a progressive myeloneuropathy; these effects being 
observed, for instance, in patients receiving prolonged exclusive tube feeds or parenteral 
nutrition 52. In utero, Cu deficiency may result in impaired development of the cardiovascular 
system, bone malformation and ongoing neurologic and immunologic abnormalities into 
infancy and beyond51. In adulthood, Qu and co-workers found that low concentrations of 
serum Cu lead to lower bone mass density, weaken bone formation and mineralization and 
impaired cartilage integrity 54. Cu deficiency has been associated with alterations in 
cholesterol metabolism; there appears to exist a negative relationship between dietary or 
serum Cu and total and LDL-cholesterol, and a positive association with cholesterol HDL, 
suggesting that a high Cu intake and status is associated with a better metabolic profile 51. 
Genetic alterations in the homeostasis of Cu originate disease. Wilson’s disease results from 
mutations in ATP7B, copper-transporting P-type ATPase, causing hepatic and neuronal 
copper accumulation, which leads to liver failure and neurological problems (movement 
disorders, seizures, and depression). It can be managed by low Cu diets, chelation therapy, Zn 
administration or liver transplant 55. Menkes’s disease is a congenital neurodegenerative 
disorder caused by ATP7A gene mutations, that causes reduce copper absorption, leading to 
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copper deficiency. Clinical features include epilepsy, growth delay, reduced muscle strength, 
skin laxity, abnormal hair, and urologic abnormalities 56. 
Another different concern, more prevalent in recent years, due to the increasing consumption 
of dietary supplements containing Cu, is excess exogenous copper uptake and copper 
exposure, which also can lead to health problems. Excessive copper produces large amounts 
of free radicals that cause lipid peroxidation and interfere with bone metabolism, leading to a 
decrease in bone cortex and bone strength 54. There is a potential link between excess Cu and 
neurological disease: Parkinson’s disease (as Cu is associated with the accelerated 
aggregation of the α-synuclein protein), Huntington’s disease (Cu has been shown to promote 
the aggregation of mutant polyglutamine repeat proteins), and Alzheimer’s disease (Cu 
increases the oligomerization of the amyloid-beta peptide) 57, 58. 
This metal has been exploited in pharmacology, where it appears in new compounds having 
interesting roles. A high number of copper-based complexes are now under investigation, 
mainly due to the therapeutic potential, which is increased by coordinating copper(II) 
complexes with mono- or polidentate Schiff bases chelates, or other donors 59. Cu-complexes 
have been proposed as potential anticancer agents, since cancer cells take up greater amounts 
of Cu than normal cells, with angiogenesis and metastasis being linked to copper 
metabolism60. Complexes formed with Cu and vitamin B1 (thiamine) as a ligand showed 
promising in vitro activity against human colon adenocarcinoma Caco-2 cells 61. Cu(II)-
niflumate complexes showed cytotoxicity against human melanoma cell line HT-144 62. Qi 
and colleagues synthesized Cu(II) compounds with thiosemicarbazone that showed antitumor 
activity against liver cancer cell (BEL-7404) in vitro, possibly related to apoptosis of cancer 
cells induced by Cu compounds through the intrinsic ROS-mediated mitochondrial pathway 
60. The antineoplastic activity of copper complexes was evaluated in vitro against human 
cervical cancer (HeLa) cells, and results showed that the copper complex exhibited 
significant growth inhibition of these cells 63. 
The anti-inflammatory activity of copper complexes has also been described for several 
decades and used to treat inflammatory disorders, such as rheumatoid arthritis, and some 
ligands that enhanced the oral or dermal absorption of copper(II) were investigated 64.  
Hussain and co-workers have synthesized copper complexes with anticancer and anti-
inflammatory activities that produced significant dose-dependent and potent analgesic and 
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anti-inflammatory effects and significant antipyretic activity only at 100 mg/kg 65. 
Furthermore, they confirmed the interaction of complexes with cyclooxygenase 2, which can 
be a mechanism of action of these potential candidates for anti-inflammatory drugs. Cu 
complexes also show antimicrobial activity; dithiocarbazate-copper(II) complexes were 
evaluated against multiresistant clinical isolates and certified microbial strains, showing 
positive results, with greater activity against Gram-positive bacteria 66. Antibacterial activity 
of novel amino acids imine ligands, complexed with several metals including Cu, against 
bacteria (Bacillus subtilis, Micrococcus luteus, Escherichia coli) and fungi (Aspergillus 
niger, Candida glabrata, Saccharomyces cerevisiae) have been screened. The results showed 
that the complexes have antimicrobial activity higher than free ligands 67. 
These compounds also have a role against neurologic diseases. The copper 
bis(thiosemicarbazones) complexes were described as neuroprotective in animal models of 
Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis and cerebral 
ischemia68, 69. Moreover, they appear to act as antidepressant adjuvants, improving sertraline 
efficiency (the antidepressant and analgesic activities of the Cu-sertraline complex have been 
assessed in rats denoting a marked synergistic effect) 70.  
Manganese (Mn) 
Manganese is essential to the formation of bone and to amino acid, lipid, protein, and 
carbohydrate metabolism. It is also needed for normal immunity system, regulation of blood 
sugar and cellular energy, reproduction, digestion, and for the defence mechanisms against 
free radicals. This trace element is required for the proper function of several metalloenzymes 
such arginase, glutamine synthetase, phosphoenolpyruvate decarboxylase, and manganese 
superoxide dismutase 71, 72, 73. 
The major route of intake for Mn is via food consumption, but inhalation exposure may also 
occur 72. The richest food sources of manganese are nuts, bread and cereal products 20. The 
Adequate Intake of Mn for adult men and women is 2.3 and 1.8 mg/day, respectively, being 
the Tolerable Upper Intake Level for adults of 11 mg/day 71.  
Humans maintain stable tissue levels of Mn. This is achieved via tight homeostatic control of 
both absorption and excretion. Only a small percentage of dietary manganese is absorbed. 
Manganese is excreted very rapidly into the gut via bile. So, manganese is excreted primarily 
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in feces, being the urinary excretion low. Accordingly, potential risk for manganese toxicity 
is highest when bile excretion is low, such as in the neonate or in liver disease 71, 72.  
Although manganese is an essential mineral, the overexposure to this metal causes toxicity, 
which includes oxidative stress, mitochondrial dysfunction, protein misfolding, endoplasmic 
reticulum stress, autophagy dysregulation, apoptosis, and disruption of other metal 
homeostasis. Excessive Mn tends to accumulate in the liver, pancreas, bone, kidney and 
brain. Hepatic cirrhosis, polycythemia, hypermanganesemia, dystonia and Parkinsonism-like 
symptoms have been reported in patients with manganese poisoning 74. For example, there is 
a report of a possible neurotoxicity case resulting from manganese excessive consumes over a 
period of years. A 37-year-old female had an incorrect dietary supplement for osteoporosis 
and was exposed to chronic high levels of manganese, possibly causing Parkinson’s disease 
via manganism 75. It should be noted that most of clinically reported cases of Mn intoxication 
are due to occupational exposure 74. On the other hand, there are few reports of manganese 
deficiency in humans, having been described cases of transient dermatitis, 
hypercholesterolaemia, development of osteoporosis in women 20.   
There are several manganese complexes with pharmacological activities, as exemplified 
below. 
Two Mn(II) complexes with heterocyclic substituted thiosemicarbazones were studied and in 
vitro tests showed significant antitumor activity against K562 leucocythemia cancer cell line. 
However, complex with 2-acetylpyridine N(4)-methylthiosemicarbazone as ligand revealed 
higher antitumor activity than complex with 2-acetylpyridine thiosemicarbazone, which 
indicate that these compounds showed that the presence of bulky groups at position N(4) of 
the thiosemicarbazone moiety enhanced the antitumor activities 76. 
Zhang and co-workers synthesized three transition metal complexes being one of Mn(II) 77. 
This complex revealed antiproliferative activity showing strong inhibition ratio against 
human hepatoma cells and moderate inhibition ratio against human gastric cancer cells in 
vitro. 
Barut and colleagues synthesized and studied peripherally tetra-substituted manganese(III) 
phthalocyanines 78. Manganese(III) phthalocyanine and it water soluble derivative were 
synthesized from 4-[2-(2-Morpholin-4-ylethoxy)ethoxy]phthalonitrile and MnCl2. These 
compounds have potential anticancer activity due to inhibition of the topoisomerase I enzyme 
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in a dose dependent manner. The intrinsic binding constant, Kb, for the water-soluble 
derivative, was 4.53 ± (0.34) ×107 M-1. So, this Mn(III) compound is a stronger binding than 
anticancer agents irinotecan, idarubicin and doxorubicin, that have Kb values in the range 
104 - 106 M-1, with lesser side effect. 
Ascorbate (Asc) has anticancer effect which has origin in the production of tumoricidal 
hydrogen peroxide during ascorbate oxidation catalyzed by endogenous metalloproteins. 
Based on this, Tovmasyan and co-workers have studied 14 Mn porphyrins (MnPs) which 
differ in their redox properties, charge, size/bulkiness and lipophilicity 79. The anticancer 
potential of MnPs/Asc system was tested in cellular (human MCF-7, MDA-MB-231 and 
mouse 4T1) and animal models of breast cancer. At the concentrations where ascorbate 
(1 mM) and MnPs (1 or 5 M) alone did not trigger any alteration in cell viability, combined 
treatment suppressed cell viability up to 95%. But the combination of ascorbate (4 g/kg) and 
MnTE-2-PyP5+ (0.2 mg/kg) showed significant suppression of a 4T1 mammary mouse flank 
tumor relative to either MnTE-2-PyP5+ or ascorbate alone. 
Tarushi and contributors synthesized and studied the biological properties of two manganese 
complexes with the anti-inﬂammatory drug mefenamic acid 80. The difference between the 
two compounds is the presence (complexe 1) or absence (complexe 2) of salicylaldoxime 
group. They have investigated the affinity of the Mg complexes to calf-thymus DNA and 
their binding towards bovine or human serum albumins. Both complexes can bind tightly to 
calf-thymus DNA by intercalation. The albumins binding constants (105-106 M-1) of the 
complexes may be considered relatively high disclosing the potency of the complexes to get 
bound by the albumins for their potential transportation. These values are much lower than 
the values of the binding constant of avidin, proposing that the binding of the complexes to 
the albumins is reversible and noncovalent and showing the ability of the complexes to get 
released when they are transferred successfully at their potential biological targets. Complex 
2 also revealed activity in human breast cancer cells, acting as an estrogen receptor alpha 
antagonist, and as a down-regulator for DEK proto-oncogene, a novel estrogen receptor α 
target gene whose expression promotes estrogen-induced proliferation.  
A study carried out by Carballala and co-workers proved that cationic manganese(III) ortho 
N-substituted pyridylporphyrins (MnP) act as a potential antioxidant towards peroxynitrite 81. 
Using resonance Raman spectroscopy, they concluded that MnP catalyzed superoxide 
dismutation and accelerated peroxynitrite reduction. In fact, Mn(III)P can be incorporated 
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into endothelial cells, reduced to Mn(II) and oxidized by peroxynitrite. The results of this 
study show that MnP protected endothelial cells from peroxynitrite-mediated nitro-oxidative 
damage, conserving mitochondrial function and preventing apoptosis. 
Antioxidant and anti-inflammatory activities of three manganese complexes of tail-tied aza-
scorpiand ligands have been study. Mn(II) complexes in which two polyazacyclophane 
macrocycles have been connected by pyridine, phenanthroline and bipyridine spacers have 
evidenced anti-inflammatory effect in human macrophages and significant antioxidant 
properties. Regarding the anti-inflammatory activity, the complex with the molar ratio 2 
Mn2+: pyridine showed the greatest efficacy 82. 
Manganese complexes derived from 2-acetylpyridine-N(4)-R-thiosemicarbazones have 
showed potential anti-Mycobacterium tuberculosis activity. These compounds have 
evidenced low cytotoxicity against eukaryotic cells and selectivity index values comparable 
or better than some commercial drugs used for the tuberculosis treatment 83. Manganese(II) 
complexes containing 1,10-phenanthroline and dicarboxylate ligands also inhibited the 
viability of M. tuberculosis strains with high selectivity and low toxicity, being a promise 
new drug for the treatment of Mycobacterium tuberculosis 84. 
Fluorine (F) 
Fluoride (F-), the negative ion of the element fluorine, is ubiquitary, present in drinking 
water, foods and air. After consumption, 90% of fluoride is absorbed in the gastrointestinal 
tract (up to 25% in the stomach and around 77% in duoden). While adults retain around 36% 
of F-, children retain 50%, 99% of that is contained in mineralized tissues (bone and teeth). 
The remaining part of the absorbed fluoride is excreted mainly into the urine 85. 
The major medicinal role by which fluoride is known is dental caries prevention. Low levels 
of F- in saliva inhibit the demineralization, enhance the remineralization of enamel, affect the 
metabolic activity of cariogenic bacteria and when ingested during the period of tooth 
development, it makes the enamel more resistant. Fluoride can be administrated in toothpaste, 
pills, mouthwash or varnishes, but fluoridation of community drinking water (usually at the 
level of 0.7-1.2 ppm) is the most cost-effective method of delivering fluoride, being 
implemented in some countries. If the fluoride level in the water is below 0.3 ppm, 
supplementation is recommended from the age of 6 months, and from the age of 3 years if the 
level falls between 0.3 and 0.6 ppm 86, 87. 
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Excess fluoride in the organism, however, has deleterious effects. Fluoride has been found to 
inhibit the activity of many enzymes, such as pyruvate kinase, succinate dehydrogenase, 
cytochrome oxidase and cholinesterases, among many others; the toxic action of fluoride is 
caused by inhibiting enzyme activities and, ultimately, interrupting metabolic processes 88. 
Acute exposure to high concentrations of fluoride results in immediate effects: abdominal 
pain, excessive saliva, nausea and vomiting. Acute effects of inhalation of hydrogen fluoride 
are severe irritation of the respiratory tract, with coughing, choking and pulmonary oedema 
87. 
Chronic high fluoride ingestion during tooth formation causes fluorosis, a hypomineralized 
enamel subsurface with an opaque appearance, progressing to pitting and a loss of the enamel 
surface and secondary brown staining 89. At fluoride intakes above 6 mg/day, fluoride 
accumulates progressively in the bone, causing skeletal fluorosis. Early symptoms include 
stiffness and pain in the joints 87. 
There seems to be other prejudicial effects of fluoride, as decreased cognitive ability, with 
evidences suggesting that it may be neurotoxic to children, cause endocrine disruption, 
causing thyroid and parathyroid problems, cause cancer and a myriad of other health 
problems 90, 91. 
Another area of interest is the use of fluorine in pharmacological active compounds. The 
isosteric substitutions of a hydrogen atom or a methyl or hydroxyl group by a fluorine atom 
are common strategies in drug development since fluorine exerts strong field and inductive 
effects92. The substitution of hydrogen atoms or functional groups by fluorine can bring 
modulation of the acidity and lipophilicity, which may result in an improvement of 
pharmacological properties. Another useful approach is the blocking of potential oxidation 
sites in order to prevent undesired metabolic pathways, exemplified in the replacement of 
methyl-arene substituents by trifluoromethyl 93. Fluorine containing drugs include: 
- Anti-inflammatory drugs: Betamethasone, dexamethasone and fluticasone are examples 
of fluorinated steroidal anti-inflammatories. Fluorine substitution in steroids is beneficial in 
blocking metabolic pathways (particularly hydroxylation, and also in modifying reactivity of 
adjacent hydrogen functions 94. Flurbiprofen, etofenamate, flufenamic acid and celecoxib are 
examples of non-steroidal anti-inflammatory drugs containing F. The replacement of 
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hydrogen with fluorine can produce isosteric analogues with improved pharmacodynamics 
characteristics.  
- Anticancer drugs: 5-fluorouracil, a tumor-inhibiting agent was the first fluorinated 
anticancer drug to be introduced in the market, in the middle of last century. Since then a 
myriad of new fluorinated anticancer drugs has been synthetized 95. New molecules, as 
afatinib or dacomitinib, are described by Zhou and co-workers 93. 
- Inhalation anesthetics: Fluorination of inhalation anesthetics was first conducted in 1951 
to eliminate the fire hazard posed by some of the anesthetics in use at the time 96. Halothane, 
isoflurane and sevoflurane were synthesized since then. 
- Antibiotics and anti-viral drugs: Numerous fluorinated quinolone (fluoroquinolones), as 
ofloxacin or ciprofloxacin, have been made, and appear to have superior properties in 
comparison to non-fluorinated compounds. More recently, other F containing antibiotics 
(tedizolid, solithromicin) and anti-viral drugs (sofosbuvir) are under development 93. 
- Neuroleptics and anti-depressants: Introduction of F in these molecules increases their 
lipophilicity and enhances the blood-brain barrier cross-over. Fluoxetine, paroxetine, 
citalopram and fluvoxamine are fluorinated antidepressants, widely used for the treatment of 
depression and anxiety disorders with great success. Edivoxetine is a more recent molecule 
93. In anti-psychotics, haloperidol was the first F-containing molecule, still in use to this day, 
and blonanserin is a recent developed drug 97. 
- Statins: Rosuvastatin, fluvastatin and atorvastatin are type 2 statins, in which the butyryl 
group of type 1 statins was replaced with a fluorophenyl group that increases binding and 
inhibition of the HMGR (3-hydroxy-3-methylglutaryl coenzyme A redutase) enzyme 98. 
- Oral antidiabetic drugs: recent drugs, as sitagliptin (a dipeptidyl peptidase-4 inhibitor) or 
canagliflozin (a sodium-glucose cotransporter-2 inhibitor) are oral antidiabetic drugs that 
contain F. 
Moreover, 18F can be used in imagiology for radiolabeling (Positron Emission Tomography, 
PET) and 19F in nuclear magnetic resonance imaging (MRI), important techniques in 
medicine99, 100. 
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Nevertheless, some careful use of fluorinated drugs must be emphasized, since defluorination 
of fluorinated drugs can readily occur during biotransformation or may also occur 
spontaneously and can be deleterious for human health 88. 
CONCLUSION 
Trace elements also known as trace minerals, are the chemical components that naturally 
occur in soil, plant, and wildlife in minute concentrations. Is this review it was reported that 
they are necessary for the optimal development and metabolic functioning such as proper cell 
metabolism, effective immune function, and healthy reproduction of humans. Thus, their role 
and homeostasis in living organisms varies. In closing, as we view the importance of trace 
elements in living organisms, detailed studies indicate a fine balance must be obtained in 
trace elements concentration in order to secure health and even to maintain life in living 
organisms.  
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